MEPIRAPIM
 | |
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| PubChem (CID) | 101896603 |
| ChemSpider | 52085735 |
| Chemical and physical data | |
| Formula | C19H27N3O |
| Molar mass | 313.45 g·mol−1 |
| 3D model (Jmol) | Interactive image |
| |
| |
MEPIRAPIM is a indole-based cannabinoid which differs from JWH-018 by having a 4-methylpiperazine group in place of the naphthyl group[1] and has been used as an active ingredient in synthetic cannabis products. It was first identified in Japan in 2013, alongside FUBIMINA.[2]
Legality
Sweden's public health agency suggested to classify MEPIRAPIM as hazardous substance on November 10, 2014.[3]
See also
References
- ↑ "MEPIRAPIM". Cayman Chemical. Retrieved 23 June 2015.
- ↑ Uchiyama N, Shimokawa Y, Matsuda S, Kawamura M, Kikura-Hanajiri R, Goda Y (January 2014). "Two new synthetic cannabinoids, AM-2201 benzimidazole analog (FUBIMINA) and (4-methylpiperazin-1-yl)(1-pentyl-1H-indol-3-yl)methanone (MEPIRAPIM), and three phenethylamine derivatives, 25H-NBOMe 3,4,5-trimethoxybenzyl analog, 25B-NBOMe, and 2C-N-NBOMe, identified in illegal products". Forensic Toxicology. 32 (1): 105–115. doi:10.1007/s11419-013-0217-2.
- ↑ "Cannabinoider föreslås bli klassade som hälsofarlig vara". Retrieved 29 June 2015.
This article is issued from Wikipedia - version of the 9/15/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.